Exagen Inc.
XGN
$3.33
-$0.04-1.19%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/12/2025
-
MarketBeat
3/12/2025
-
Simply Wall St
3/12/2025
-
TipRanks Financial Blog
3/12/2025
-
GuruFocus
3/12/2025
-
GuruFocus
3/12/2025
-
TipRanks Financial Blog
3/11/2025
-
SeekingAlpha
3/11/2025
-
Seeking Alpha: Transcripts
3/11/2025
-
Ticker Report
3/11/2025
-
Zacks Investment Research
3/11/2025
-
GuruFocus
3/11/2025
-
TipRanks Financial Blog
3/11/2025
-
TipRanks Financial Blog
3/11/2025
-
The Fly
3/11/2025
-
The Fly
3/11/2025
-
Globe Newswire
3/6/2025
-
MarketBeat
3/4/2025
-
Simply Wall St
2/25/2025
-
GuruFocus
2/25/2025
-
Globe Newswire
2/16/2025
-
Ticker Report
2/13/2025
-
MarketBeat
2/13/2025
-
Ticker Report
2/5/2025
-
Simply Wall St
2/5/2025
-
Zacks Investment Research
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, November 12, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Mar 17 and 21 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
760 560 1501
Address
1261 Liberty Way
Vista, CA 92081
Vista, CA 92081
Country
Year Founded
Business Description
Sector
Exagen Inc. develops and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis...
more